Secure-IC's Securyzr(TM) Network Security Crypto Accelerator
Fundamental Inventions Enable the Best PPA and Most Portable eFPGA/DSP/SDR/AI IP for Adaptable SoCs
Flex Logix Patents & Applications Surpass 100
MOUNTAIN VIEW, Calif. , April 25, 2024 -- Flex Logix® Technologies, Inc., the leading supplier of embedded FPGA (eFPGA) IP and reconfigurable DSP/SDR/AI solutions, announced that it now has over 100 total worldwide patents and applications on fundamental inventions that enable the best reconfigurable solutions for FPGA, DSP/SDR and AI.
EFLX eFPGA has PPA (power/performance/area) metrics comparable to the established FPGA suppliers. And EFLX is available or in design for over a dozen nodes from 180nm to 18A. This enables SoCs to incorporate power and cost effective flexibility for changing algorithms, standards and customer needs. A traditional FPGA fabric is designed over several years by 50-100 engineers. Flex Logix delivers similar results in less than a year with a 1/10th of the people. This is because Flex Logix has numerous fundamental inventions for a very different type of interconnect that uses half the transistors and half the metal layers. And Flex Logix has more inventions allowing a modular design approach to span customer needs from 200 to >1 Million LUTs (and DSP/BRAM).
InferX DSP/SDR/AI PPA is superior to existing IP solutions and is fully reconfigurable. This is because of fundamental inventions that allow for arrays of hard wired TPUs to be controlled with very high utilization of compute resources by Softlogic operators running on EFLX eFPGA that controls execution.
"I am proud of the culture of practical innovation in the Flex Logix hardware and software team," said Geoff Tate, CEO of Flex Logix. "From Cheng Wang, our CTO/SVP, down our team constantly innovates to find better solutions to customers' needs. This has resulted in us becoming the leading eFPGA supplier with dozens of customers and now a supplier of the best reconfigurable DSP/SDR/AI."
About Flex Logix
Flex Logix is a reconfigurable computing company providing leading edge eFPGA, DSP/SDR and AI Inference solutions for semiconductor and systems companies. Flex Logix eFPGA enables volume FPGA users to integrate the FPGA into their companion SoC, resulting in a 5-10x reduction in the cost and power of the FPGA and increasing compute density which is critical for communications, networking, data centers, microcontrollers and others. Its scalable DSP/SDR/AI is the most efficient, providing much higher inference throughput per square millimeter and per watt. Flex Logix supports process nodes from 180nm to 7nm, with 5nm, 3nm and 18A in development. Flex Logix is headquartered in Mountain View, California and has an office in Austin, Texas. For more information, visit https://flex-logix.com.
For general information on InferX and EFLX product lines, visit our website at this link.
|
Related News
- Industry Leading PPA DSP Available For All Existing EFLX eFPGA
- Flex Logix Boosts AI Accelerator Performance and Long-Term Efficiency
- Flex Logix Cancels AI Chip, Markets IP for AI and DSP
- Flex Logix Announces InferX™ High Performance IP for DSP and AI Inference
- Flex Logix and CEVA Announce First Working Silicon of a DSP with Embedded FPGA to Allow a Flexible/Changeable ISA
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |